The enantioselective synthesis of mexiprostil (16R-16-methoxy-16-methyl PGE1 methyl ester) is described. The assembly of the prostaglandin framework has been accomplished by the throe component coupling process, via consecutive linking of the omega and alpha-sidechain to unsubstituted (R)-4-hydroxy-2-cyclopentenone, and alternatively by a conjugate addition of the omega-side chain to a (R)-4-hydroxy-2-cyclopentenone in which the alpha-side chain is already incorporated. The required lower side chain building block is prepared enantioselectively from nerol utilising the Sharpless expoxidation reaction.
A practical synthesis of the ω side-chain unit present in mexiprostil and its use for synthesis of mexiprostil via two-component coupling process.
作者:Sentaro Okamoto、Toshiharu Yoshino、Fumie Sato
DOI:10.1016/s0957-4166(00)82153-9
日期:1991.1
A practical synthesis of the optically active omega side-chain unit present in mexiprostil, a PGE1 analogue, by starting from readily available optically pure 4 has been developed. Synthesis of mexiprostil via two-component coupling process by using the omega side-chain thus prepared has been carried out.
KOLB, MICHAEL;VAN, HIJFTE LUC
作者:KOLB, MICHAEL、VAN, HIJFTE LUC
DOI:——
日期:——
KOLB, M.;VAN, HIJFTE L.;IRELAND, R. E., TETRAHEDRON LETT., 29,(1988) N 51, C. 6769-6772
作者:KOLB, M.、VAN, HIJFTE L.、IRELAND, R. E.
DOI:——
日期:——
Novel process and intermediates
申请人:Merrell Dow Pharmaceuticals
公开号:US05055592A1
公开(公告)日:1991-10-08
This invention relates to the novel processes for the preparation of a 16-methoxy-16-methyl prostaglandin E.sub.1 derivative and to the novel intermediates useful therefor.
The enantioselective synthesis of mexiprostil (16R-16-methoxy-16-methyl PGE1 methyl ester) is described. The assembly of the prostaglandin framework has been accomplished by the throe component coupling process, via consecutive linking of the omega and alpha-sidechain to unsubstituted (R)-4-hydroxy-2-cyclopentenone, and alternatively by a conjugate addition of the omega-side chain to a (R)-4-hydroxy-2-cyclopentenone in which the alpha-side chain is already incorporated. The required lower side chain building block is prepared enantioselectively from nerol utilising the Sharpless expoxidation reaction.